EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Serum 1,25-Dihydroxyvitamin D Levels Across Stages of Chronic Kidney Disease: A Cross-Sectional Study in Bangladesh

Mohammad Tariqul Islam, Masud Iqbal, Suman Chandra Roy, Maleka Ali, Samawat Naiyer Shahid, Sarif Mahammad Salauddin, Md Afzalul Bashar

TAJ: Journal of Teachers Association · 01.06.2026 · 39 (2) · 195-201

DOI: 10.70818/taj.v39i2.0680 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift TAJ: Journal of Teachers Association, online erschienen am 01.06.2026. Verfasst von Mohammad Tariqul Islam und 6 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is associated with dysregulation of vitamin D metabolism and mineral homeostasis. Reduced renal activation of vitamin D leads to decreased circulating levels of 1,25-dihydroxyvitamin D and contributes to CKD-mineral and bone disorder (CKD-MBD). Understanding changes in active vitamin D levels across CKD stages may help identify metabolic complications associated with disease progression.

Objective

To assess the serum levels of 1,25-dihydroxyvitamin D in patients with chronic kidney disease (CKD) stages G3-G5 and to assess its correlation with other laboratory parameters.

Methods

This cross-sectional observational study was conducted in the Department of Nephrology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh, from April to December 2020. A total of 75 patients with CKD stages G3–G5 were selected using purposive sampling. Clinical and laboratory data were collected from medical records and a semi-structured questionnaire. Serum 1,25-dihydroxyvitamin D and other biochemical parameters were analyzed. Independent sample t-test, one-way ANOVA, and Pearson correlation tests were used for statistical analysis.

Results

The mean serum 1,25-dihydroxyvitamin D level was 26.00 ± 16.45 pg/mL. A progressive decline in serum 1,25-dihydroxyvitamin D levels was observed with advancing CKD stage. Mean levels were 32.78 ± 18.67 pg/mL in stage G3, 29.33 ± 16.27 pg/mL in stage G4, and 18.37 ± 10.17 pg/mL in stage G5, showing a statistically significant difference among stages (p = 0.007). Serum 1,25-dihydroxyvitamin D demonstrated a significant positive correlation with eGFR (r = 0.415, p < 0.001) and 25-hydroxyvitamin D (r = 0.259, p = 0.031).

Conclusion

Serum 1,25-dihydroxyvitamin D levels decreased significantly with increasing CKD stage and were closely associated with kidney function and phosphorus metabolism. Dynamic monitoring of active vitamin D may help to identify CKD-MBD-related metabolic disorders in an early stage.

Zitieren

APA

Islam, M. T., Iqbal, M., Roy, S. C., Ali, M., Shahid, S. N., Salauddin, S. M., & Bashar, M. A. (2026). Serum 1,25-Dihydroxyvitamin D Levels Across Stages of Chronic Kidney Disease: A Cross-Sectional Study in Bangladesh. TAJ: Journal of Teachers Association, 39(2), 195-201. https://doi.org/10.70818/taj.v39i2.0680

Vancouver

Islam MT, Iqbal M, Roy SC, Ali M, Shahid SN, Salauddin SM, et al. Serum 1,25-Dihydroxyvitamin D Levels Across Stages of Chronic Kidney Disease: A Cross-Sectional Study in Bangladesh. TAJ: Journal of Teachers Association. 2026;39(2):195-201. doi:10.70818/taj.v39i2.0680

BibTeX
@article{Islam2026,
  author = {Islam, Mohammad Tariqul and Iqbal, Masud and Roy, Suman Chandra and Ali, Maleka and Shahid, Samawat Naiyer and Salauddin, Sarif Mahammad and Bashar, Md Afzalul},
  title = {Serum 1,25-Dihydroxyvitamin D Levels Across Stages of Chronic Kidney Disease: A Cross-Sectional Study in Bangladesh},
  journal = {TAJ: Journal of Teachers Association},
  year = {2026},
  volume = {39},
  number = {2},
  pages = {195--201},
  doi = {10.70818/taj.v39i2.0680}
}
Kostenlos starten →